Kala Pharmaceuticals
company
Funding Round
Post-IPO Equity
Money Raised
$ 16.12M
Propotion
-
Post Valuation
-
Current Round Investors
| Investor Name | Invest Money | Lead Investor | Propotion |
|---|
Historical Financing
| Announced Date | Round | Money Raised | Investors | |
|---|---|---|---|---|
| Oct 3, 2018 | Post-IPO Equity | $ 110M | Athyrium Capital Management LP | Detail |
| Apr 13, 2016 | Series C | $ 68M | CAM Capital,Longitude Capital,etc. | Detail |
| Feb 28, 2013 | Series A | $ 11.50M | Crown Venture Fund,Lux Capital,etc. | Detail |
| Apr 23, 2014 | Series B | $ 22.50M | AbbVie Biotech Ventures,Crown Venture Fund,etc. | Detail |
| Dec 24, 2009 | Series A | $ 2M | Detail | |
| May 12, 2021 | Post-IPO Debt | $ 125M | Oxford Finance LLC | Detail |
| Mar 14, 2012 | Private Equity（PE） | $ 7.24M | Lighthouse Capital Partners,Lux Capital,etc. | Detail |
| Nov 10, 2010 | Series Unknown | $ 3M | Detail | |
| Apr 6, 2020 | Post-IPO Equity | $ 134M | Detail | |
| Aug 17, 2015 | Series Unknown | $ 6.99M | Detail | |
| Jul 20, 2017 | IPO | $ 90M | Detail |
